Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.

Tonelli M, Wiebe N, Guthrie B, James MT, Quan H, Fortin M, Klarenbach SW, Sargious P, Straus S, Lewanczuk R, Ronksley PE, Manns BJ, Hemmelgarn BR.

Kidney Int. 2015 Oct;88(4):859-66. doi: 10.1038/ki.2015.228. Epub 2015 Jul 29.

PMID:
26221754
2.

Relocation of remote dwellers living with hemodialysis: a time trade-off survey.

Tonelli M, Molzahn AE, Wiebe N, Davison SN, Gill JS, Hemmelgarn BR, Manns BJ, Pannu N, Pelletier R, Thompson S, Klarenbach SW; Alberta Kidney Disease Network.

Nephrol Dial Transplant. 2015 Oct;30(10):1767-73. doi: 10.1093/ndt/gfv112. Epub 2015 Jun 1.

PMID:
26038350
3.

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.

Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, Wiebe N, Ruospo M, Wheeler DC, Strippoli GF.

Lancet. 2015 May 23;385(9982):2047-56. doi: 10.1016/S0140-6736(14)62459-4. Review.

4.

Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.

Maxwell JP, Wang C, Wiebe N, Yilmaz A, Trpkov K.

Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z.

5.

Methods for identifying 30 chronic conditions: application to administrative data.

Tonelli M, Wiebe N, Fortin M, Guthrie B, Hemmelgarn BR, James MT, Klarenbach SW, Lewanczuk R, Manns BJ, Ronksley P, Sargious P, Straus S, Quan H; Alberta Kidney Disease Network.

BMC Med Inform Decis Mak. 2015 Apr 17;15:31. doi: 10.1186/s12911-015-0155-5.

6.

Trace element supplementation in hemodialysis patients: a randomized controlled trial.

Tonelli M, Wiebe N, Thompson S, Kinniburgh D, Klarenbach SW, Walsh M, Bello AK, Faruque L, Field C, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2015 Apr 11;16:52. doi: 10.1186/s12882-015-0042-4.

7.

Cause of Death in Patients with Reduced Kidney Function.

Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, Tonelli M; Alberta Kidney Disease Network.

J Am Soc Nephrol. 2015 Oct;26(10):2504-11. doi: 10.1681/ASN.2014070714. Epub 2015 Mar 2.

PMID:
25733525
8.

Evidence-based decision-making 2: Systematic reviews and meta-analysis.

Bello A, Wiebe N, Garg A, Tonelli M.

Methods Mol Biol. 2015;1281:397-416. doi: 10.1007/978-1-4939-2428-8_24.

PMID:
25694324
9.

Neurologists' knowledge of and attitudes toward epilepsy surgery: a national survey.

Roberts JI, Hrazdil C, Wiebe S, Sauro K, Vautour M, Wiebe N, Jetté N.

Neurology. 2015 Jan 13;84(2):159-66. doi: 10.1212/WNL.0000000000001127. Epub 2014 Dec 10.

10.

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF.

Cochrane Database Syst Rev. 2014 Dec 8;12:CD010590. doi: 10.1002/14651858.CD010590.pub2. Review.

PMID:
25486075
11.

Buttonhole versus rope-ladder cannulation of arteriovenous fistulas for hemodialysis: a systematic review.

Wong B, Muneer M, Wiebe N, Storie D, Shurraw S, Pannu N, Klarenbach S, Grudzinski A, Nesrallah G, Pauly RP.

Am J Kidney Dis. 2014 Dec;64(6):918-36. doi: 10.1053/j.ajkd.2014.06.018. Epub 2014 Aug 8. Review.

PMID:
25110302
12.

Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.

Faruque LI, Lin M, Battistella M, Wiebe N, Reiman T, Hemmelgarn B, Thomas C, Tonelli M.

PLoS One. 2014 Jul 2;9(7):e101145. doi: 10.1371/journal.pone.0101145. eCollection 2014. Review.

13.

The protocol for the Families First Edmonton trial (FFE): a randomized community-based trial to compare four service integration approaches for families with low-income.

Drummond J, Schnirer L, So S, Mayan M, Williamson DL, Bisanz J, Fassbender K, Wiebe N.

BMC Health Serv Res. 2014 May 19;14:223. doi: 10.1186/1472-6963-14-223.

14.

Hamiltonian learning and certification using quantum resources.

Wiebe N, Granade C, Ferrie C, Cory DG.

Phys Rev Lett. 2014 May 16;112(19):190501. Epub 2014 May 14.

PMID:
24877920
15.

Potentially preventable hospitalization as a complication of CKD: a cohort study.

Wiebe N, Klarenbach SW, Allan GM, Manns BJ, Pelletier R, James MT, Bello A, Hemmelgarn BR, Tonelli M; Alberta Kidney Disease Network.

Am J Kidney Dis. 2014 Aug;64(2):230-8. doi: 10.1053/j.ajkd.2014.03.012. Epub 2014 Apr 13.

PMID:
24731738
16.

Patient satisfaction with care in epilepsy: how much do we know?

Wiebe N, Fiest KM, Dykeman J, Liu X, Jette N, Patten S, Wiebe S.

Epilepsia. 2014 Mar;55(3):448-55. doi: 10.1111/epi.12537. Epub 2014 Feb 6. Review.

17.

A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout.

Faruque LI, Ehteshami-Afshar A, Wiebe N, Tjosvold L, Homik J, Tonelli M.

Semin Arthritis Rheum. 2013 Dec;43(3):367-75. doi: 10.1016/j.semarthrit.2013.05.004. Review.

PMID:
24326033
18.

Kidney stones and cardiovascular events: a cohort study.

Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2014 Mar;9(3):506-12. doi: 10.2215/CJN.04960513. Epub 2013 Dec 5.

19.

Information-theoretic equilibration: the appearance of irreversibility under complex quantum dynamics.

Ududec C, Wiebe N, Emerson J.

Phys Rev Lett. 2013 Aug 23;111(8):080403. Epub 2013 Aug 20.

PMID:
24010417
20.

Factors associated with initiation of chronic renal replacement therapy for patients with kidney failure.

Faruque LI, Hemmelgarn BR, Wiebe N, Manns BJ, Ravani P, Klarenbach S, Pelletier R, Tonelli M; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1327-35. doi: 10.2215/CJN.10721012. Epub 2013 Jul 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk